Clinical Trial Update: A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection [Phase 2]

View source ↗

Summary

Phase 2 study in kidney transplant recipients at high risk of cytomegalovirus infection; results posted from a Nobelpharma-sponsored trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Disease

Drugs mentioned

• Undisclosed investigational product

Snippet

Sponsor: Nobelpharma | Conditions: Cytomegalovirus Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-06-28